<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T00:02:49Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14446" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14446</identifier><datestamp>2026-10-18T21:14:22Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Obesity-related metabolic and endocrine disorders diagnosed during postoperative follow-up of slipped capital femoral epiphysis</dc:title><dc:creator>Ucpunar, Hanifi</dc:creator><dc:creator>Camurcu, Ismet Yalkin</dc:creator><dc:creator>Duman, Serda</dc:creator><dc:creator>Ucpunar, Esra</dc:creator><dc:creator>Sofu, Hakan</dc:creator><dc:creator>Bayhan, Avni Ilhan</dc:creator><dc:subject>Adolescent</dc:subject><dc:subject>Child</dc:subject><dc:subject>Diabetes Mellitus, Type 2</dc:subject><dc:subject>Dyslipidemias</dc:subject><dc:subject>Female</dc:subject><dc:subject>Humans</dc:subject><dc:subject>Male</dc:subject><dc:subject>Obesity</dc:subject><dc:subject>Postoperative Period</dc:subject><dc:subject>Prevalence</dc:subject><dc:subject>Retrospective Studies</dc:subject><dc:subject>Slipped Capital Femoral Epiphyses</dc:subject><dc:subject>Vitamin D Deficiency</dc:subject><dc:subject>Young Adult</dc:subject><dc:subject>alanine aminotransferase</dc:subject><dc:subject>aspartate aminotransferase</dc:subject><dc:subject>cholesterol</dc:subject><dc:subject>creatinine</dc:subject><dc:subject>glucose</dc:subject><dc:subject>hemoglobin A1c</dc:subject><dc:subject>high density lipoprotein cholesterol</dc:subject><dc:subject>liothyronine</dc:subject><dc:subject>low density lipoprotein cholesterol</dc:subject><dc:subject>thyrotropin</dc:subject><dc:subject>triacylglycerol</dc:subject><dc:subject>urea</dc:subject><dc:subject>vitamin D</dc:subject><dc:subject>adolescent obesity</dc:subject><dc:subject>alanine aminotransferase blood level</dc:subject><dc:subject>Article</dc:subject><dc:description>Background and purpose — Patients with slipped capital femoral epiphysis (SCFE) are phenotypically overweight or obese and may therefore require clinical follow-up of obesity-related disorders. We evaluated obesity-related disorders such as dyslipidemia, type 2 diabetes mellitus (DM), and vitamin-D deficiency during the postoperative period in patients with SCFE. Patients and methods — 51 patients who were operated and followed-up for SCFE and 62 healthy adolescents without SCFE (control group) were included in this retrospective study. Patients’ BMI, serum lipid profile (total cholesterol, LDL-C, HDL-C, triglyceride), fasting blood glucose, HbA1c, and serum vitamin D levels were evaluated. Results — At the time of surgery, 45 patients in the SCFE group were overweight or obese (BMI &gt;25). At the latest follow-up, 42 patients in the SCFE group and 53 patients in the control group were overweight/obese. Abnormal serum lipid profile and ratio of total dyslipidemia were similar between the groups. 8 patients had abnormal HbA1c levels in the SCFE group and mean HbA1c levels were significantly higher in the SCFE group (p = 0.03). All patients and controls had low levels of vitamin D. Interpretation — Although serum lipid profile and vitamin D levels were detected as similar in SCFE and control groups, the potential risk of type 2 DM identified via abnormal HbA1c levels was significantly higher in patients with SCFE. We recommend that patients diagnosed with SCFE should be considered as potential candidates for type 2 DM; thus follow-up after surgical treatment should include not only orthopedic outcomes but also evaluation of future risk for DM. © 2018 The Author(s). Published by Taylor &amp; Francis on behalf of the Nordic Orthopedic Federation.</dc:description><dc:publisher>Taylor and Francis Ltd</dc:publisher><dc:date>2018</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/14446</dc:identifier><dc:identifier>https://doi.org/10.1080/17453674.2018.1445167</dc:identifier><dc:identifier>1745-3674</dc:identifier><dc:language>en</dc:language><dc:relation>Acta Orthopaedica</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/14446</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>